OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2024
(6)
2025
(3)
2023
(3)
2021
(3)
2018
(3)
2022
(2)
2020
(1)
2019
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126
|
biostudies-literature
Cite
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929
|
biostudies-literature
Cite
Challenges of one-year longitudinal follow-up of a prospective, observational cohort study using an anonymised database: recommendations for trainee research collaboratives.
Not available
S-EPMC6909648
|
biostudies-literature
Cite
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Not available
S-EPMC6289056
|
biostudies-literature
Cite
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Not available
S-EPMC7255743
|
biostudies-literature
Cite
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Not available
S-EPMC8377563
|
biostudies-literature
Cite
Prediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595
|
biostudies-literature
Cite
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466
|
biostudies-literature
Cite
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Not available
S-EPMC10033295
|
biostudies-literature
Cite
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets